Stakeholder Input Sought in Evaluation of FDA Tobacco Program

Meeting Registration and Online Stakeholder Portal Now Open

(October 13, 2022) The Reagan-Udall Foundation today announced a series of upcoming virtual meetings and opened a Stakeholder Portal to solicit input for the Independent Expert Panel’s evaluation of certain portions of FDA’s tobacco program. 

“We want to hear from a broad range of stakeholders who have experience with tobacco regulation,” said Lauren Silvis, JD, Chair of the Tobacco Independent Expert Panel. “Public input is critical to the process of developing recommendations to modernize and strengthen the operations of the Center for Tobacco Products.” 

Three virtual Independent Expert Panel meetings built around key operational issues will be held later this month:

  • October 21         11am – 2pm (eastern)                    Application Process
  • October 24         1pm – 4pm (eastern)                    Regulations & Guidance Process
  • October 25         9am – Noon (eastern)                  Compliance & Enforcement                                                                                                                                                                        Public Education & Communication 

A limited number of speaking slots are available for each meeting; if individuals or organizations would like to speak at any of these sessions, requests can be submitted via the Speaker Request Form. Separately, those who want to observe the virtual meetings can visit the registration page

The online portal allows individuals and organizations to offer insight and share their experiences working with FDA’s tobacco program. Comments received through the Stakeholder Portal will be shared with the Independent Expert Panel charged with generating the recommendations for FDA. 

The tobacco evaluation focuses on Center programs for regulations and guidance, application review, compliance and enforcement, and communication with the public and other stakeholders. The panel is not addressing tobacco policy issues, which are outside the scope of this evaluation. The report will be presented to FDA Commissioner Robert Califf and posted publicly on December 19, 2022.

 


About the Reagan-Udall Foundation for the FDA

The Reagan-Udall Foundation for the FDA (FDA Foundation) is an independent 501(c)(3) created by Congress to advance regulatory science to help the U.S. Food and Drug Administration accomplish its mission. The FDA Foundation works to improve health and safety through stakeholder engagement and public-private partnerships that facilitate innovation, foster the use of real-world evidence, and identify modern tools and polices to keep pace with today’s rapidly evolving science.

Media Contacts:

Lea Ann Browning-McNee
301-509-1846 (cell)
Lmcnee@reaganudall.org  

Mary McNamara
202-276-7822 (cell)
mmcnamara@reaganudall.org